202 related articles for article (PubMed ID: 26690594)
21. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
Ramenghi U; Bonissoni S; Migliaretti G; DeFranco S; Bottarel F; Gambaruto C; DiFranco D; Priori R; Conti F; Dianzani I; Valesini G; Merletti F; Dianzani U
Blood; 2000 May; 95(10):3176-82. PubMed ID: 10807785
[TBL] [Abstract][Full Text] [Related]
23. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.
Poppema S; Maggio E; van den Berg A
Leuk Lymphoma; 2004 Mar; 45(3):423-31. PubMed ID: 15160902
[TBL] [Abstract][Full Text] [Related]
24. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Dowdell KC; Niemela JE; Price S; Davis J; Hornung RL; Oliveira JB; Puck JM; Jaffe ES; Pittaluga S; Cohen JI; Fleisher TA; Rao VK
Blood; 2010 Jun; 115(25):5164-9. PubMed ID: 20360470
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
van der Burg M; de Groot R; Comans-Bitter WM; den Hollander JC; Hooijkaas H; Neijens HJ; Berger RM; Oranje AP; Langerak AW; van Dongen JJ
Pediatr Res; 2000 Mar; 47(3):336-43. PubMed ID: 10709732
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS).
Arkwright PD; Rieux-Laucat F; Le Deist F; Stevens RF; Angus B; Cant AJ
Clin Exp Immunol; 2000 Aug; 121(2):353-7. PubMed ID: 10931153
[TBL] [Abstract][Full Text] [Related]
28. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats.
Aberdein D; Munday JS; Gandolfi B; Dittmer KE; Malik R; Garrick DJ; Lyons LA;
Mamm Genome; 2017 Feb; 28(1-2):47-55. PubMed ID: 27770190
[TBL] [Abstract][Full Text] [Related]
29. Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.
Agrebi N; Ben-Mustapha I; Matoussi N; Dhouib N; Ben-Ali M; Mekki N; Ben-Ahmed M; Larguèche B; Ben Becher S; Béjaoui M; Barbouche MR
Clin Immunol; 2017 Oct; 183():17-23. PubMed ID: 28668589
[TBL] [Abstract][Full Text] [Related]
30. Scaling the tips of the ALPS.
Rieux-Laucat F; Kanellopoulos JM; Ojcius DM
Biomed J; 2021 Aug; 44(4):383-387. PubMed ID: 34438083
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies.
Hamadou WS; Mani R; Bouali N; Besbes S; Bourdon V; El Abed R; Ben Youssef Y; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
Bull Cancer; 2021 Sep; 108(9):798-805. PubMed ID: 34140154
[TBL] [Abstract][Full Text] [Related]
32. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Pellé O; Moreno S; Lorenz MR; Riller Q; Fuehrer M; Stolzenberg MC; Maccari ME; Lenoir C; Cheminant M; Hinze T; Hebart HF; König C; Schvartz A; Schmitt Y; Vinit A; Henry E; Touzart A; Villarese P; Isnard P; Neveux N; Landman-Parker J; Picard C; Fouyssac F; Neven B; Grimbacher B; Speckmann C; Fischer A; Latour S; Schwarz K; Ehl S; Rieux-Laucat F; Rensing-Ehl A; Magérus A
J Allergy Clin Immunol; 2024 Jan; 153(1):203-215. PubMed ID: 37793571
[TBL] [Abstract][Full Text] [Related]
33. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
34. Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma.
van den Berg A; Maggio E; Diepstra A; de Jong D; van Krieken J; Poppema S
Blood; 2002 Feb; 99(4):1492-4. PubMed ID: 11830507
[TBL] [Abstract][Full Text] [Related]
35. NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
Oliveira JB; Bidère N; Niemela JE; Zheng L; Sakai K; Nix CP; Danner RL; Barb J; Munson PJ; Puck JM; Dale J; Straus SE; Fleisher TA; Lenardo MJ
Proc Natl Acad Sci U S A; 2007 May; 104(21):8953-8. PubMed ID: 17517660
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
Nabhani S; Ginzel S; Miskin H; Revel-Vilk S; Harlev D; Fleckenstein B; Hönscheid A; Oommen PT; Kuhlen M; Thiele R; Laws HJ; Borkhardt A; Stepensky P; Fischer U
Haematologica; 2015 Sep; 100(9):1189-98. PubMed ID: 26113417
[TBL] [Abstract][Full Text] [Related]
37. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
[TBL] [Abstract][Full Text] [Related]
38. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
Front Immunol; 2019; 10():1193. PubMed ID: 31191551
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities?
Palmisani E; Miano M; Grossi A; Lanciotti M; Lupia M; Terranova P; Ceccherini I; Montanari E; Calvillo M; Pierri F; Micalizzi C; Maggiore R; Guardo D; Zanardi S; Facchini E; Maggio A; Mastrodicasa E; Corti P; Russo G; Pillon M; Farruggia P; Cesaro S; Barone A; Tosetti F; Ramenghi U; Crescenzio N; Bleesing J; Dufour C; Fioredda F
Hemasphere; 2023 Mar; 7(3):e845. PubMed ID: 36844186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
